Ultimate magazine theme for WordPress.

Oxford Cannabinoid Technologies (OCTP) – Dr John Lucas, CEO & Neil Mahapatra, Executive Chairman


Oxford Cannabinoid Technologies (OCTP) is a UK-based next generation cannabis pharmaceutical company focussed on the development of cannabinoid-based prescription medicines to target indications in the £42.5bn pain market, with regulatory marketing approval from agencies including the FDA, EMA and MHRA. Established in 2017, OCTP aims to become a global leader in developing licensed prescription medicines that target the endocannabinoid system to address significant unmet medical needs.


Leave A Reply

Your email address will not be published.